Header cover image

Canadian (TSX) Biotech Industry Analysis

Updated-
DataAggregated Company Financials
Companies0
  • 7Dn/a
  • 3Mn/a
  • 1Yn/a
  • YTDn/a

Over the last 7 days, the Biotech industry has dropped 2.1%, driven by Oncolytics Biotech declining 23%. In contrast, Reunion Neuroscience has gained 59%. This takes the industry's 12 month performance to a gain of 28%. Looking forward, earnings are forecast to grow by 48% annually.

Industry Valuation and Performance

Has the Canadian Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Loading
Current Industry PE
  • Investors are optimistic on the Canadian Biotechnology industry, and appear confident in long term growth rates.
  • The industry's 3-year average PS ratio of 32.3x is exceeded by the industry's current PS ratio of 45.0x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
  • Revenues have also declined 19% per year.
  • This means overall sales from these companies are declining and losses are subsequently expanding as well.

Industry Comparison

How does Canadian Biotech compare with similar industries?

Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
REUN Reunion NeuroscienceCA$1.5158.9%
+CA$6.6m
-73.3%PS3.6x
MSCL Satellos BioscienceCA$0.609.1%
+CA$5.6m
-18.9%PB31.8x
MDNA Medicenna TherapeuticsCA$0.799.7%
+CA$4.9m
-33.1%PB1.7x
IBT IBEX TechnologiesCA$1.0022.0%
+CA$4.5m
110.5%PE17.9x
QPT Quest PharmaTechCA$0.1033.3%
+CA$4.2m
-28.6%PB0.2x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

SVA

CA$0.82

Sernova

7D

-5.7%

1Y

-46.8%

EDT

CA$0.29

Spectral Medical

7D

-7.8%

1Y

-10.6%

MPH

CA$1.19

Medicure

7D

8.2%

1Y

-10.5%

COV

CA$1.90

Covalon Technologies

7D

-11.2%

1Y

-14.0%

ONC

CA$2.24

Oncolytics Biotech

7D

-23.4%

1Y

62.3%

MSCL

CA$0.60

Satellos Bioscience

7D

9.1%

1Y

-18.9%

DTC

CA$2.75

Defence Therapeutics

7D

-1.8%

1Y

-11.3%

BLU

CA$19.63

BELLUS Health

7D

-1.0%

1Y

96.7%

GLAB

CA$0.59

Gemina Laboratories

7D

-9.2%

1Y

-13.2%

QPT

CA$0.10

Quest PharmaTech

7D

33.3%

1Y

-28.6%

PMN

CA$6.35

ProMIS Neurosciences

7D

-9.3%

1Y

-3.8%

TH

CA$1.16

Theratechnologies

7D

-7.9%

1Y

-65.8%

REUN

CA$1.51

Reunion Neuroscience

7D

58.9%

1Y

-73.3%

BCT

CA$8.40

BriaCell Therapeutics

7D

2.2%

1Y

30.8%